Clinical Trial Results:
A Multicenter, Open-label, Phase 2 Study of NT-I7 in Combination with Nivolumab in Subjects Relapsed/Refractory Gastric or Gastro-Esophageal Junction or Esophageal Adenocarcinoma who Progressed on or Intolerant to 2 or more Prior Lines of Systemic Therapy
Summary
|
|
EudraCT number |
2020-004175-41 |
Trial protocol |
PL IT ES |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Jun 2024
|
First version publication date |
06 Jun 2024
|
Other versions |
|
Summary report(s) |
Synoptic CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.